Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...
ATS Attendees pick up bags bearing the 2009 conference logo after registering for the meeting. This photo is from the ATS press room. I didn't get many of these types of shots this year because I learned last year the show photographer gets way better ones than I do. I post them only to give readers a flavor for what one of these meetings is really like. If you want to know more about what it's like to attend one of these meetings as a patient, you should ask Carmen, Izzy or Karen T. All have attended this meeting now and can tell you all about the experience.
Comments